Emyria Ltd has released a press release.
Emyria Pursuing Registration of EMD-003 in CY2021
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Emyria
- Emyria to Benefit from Final TGA Ruling on CBD Medicines
- Emyria Sees Strong Interest in IBS Study
- Emyria Launches Drug Development Program Based on RWE
- Emyria Partners with Thought Leaders in Psychedelic Therapy
- Emyria Enters Data Deal with ZLD to Support Autism Trial
Later from Emyria
- FDA Position on RWE to Guide Registration
- Emyria wins digital health monitoring grant with UWA
- Emyria adds second Emerald Clinic in Melbourne
- Emyria Adds Second Clinical Site in Perth
- Emyria and Cann Partner to Register CBD Product
Follow Emyria into a list and get an email when it puts out news.
Follow Emyria